3.65
price down icon2.14%   -0.08
after-market Handel nachbörslich: 3.71 0.06 +1.64%
loading

Finanzdaten der Prime Medicine Inc-Aktie (PRME)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
31.59%
0.838
1.225 1.115 1.454 2.183
Operating Expenses
10.42%
49.45
55.20 54.49 53.85 46.41
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
10.42%
49.45
55.20 54.49 53.85 46.41
Operating Income/Loss
9.94%
-48.61
-53.97 -53.38 -52.39 -44.22
Nonoperating Income/Loss
25.42%
2.529
3.391 0.786 0.502 1.946
Income/Loss From Continuing Operations Before Tax
31.59%
0.838
1.225 -52.59 -51.89 2.183
Income/Loss From Continuing Operations After Tax
8.90%
-46.08
-50.58 -52.59 -51.89 -42.28
Net Income/Loss
8.90%
-46.08
-50.58 -52.59 -51.89 -42.28
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
94.07%
9.5138
160.50 129.19 130.88 4.108
Diluted Average Shares
94.07%
9.5138
160.50 129.19 130.88 4.108
Basic Earnings Per Share
25.00%
-0.24
-0.32 -0.41 -0.40 -0.31
Diluted Earnings Per Share
25.00%
-0.24
-0.32 -0.41 -0.40 -0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):